Avery A. Rizio

614 total citations
29 papers, 415 citations indexed

About

Avery A. Rizio is a scholar working on Genetics, Cognitive Neuroscience and Hematology. According to data from OpenAlex, Avery A. Rizio has authored 29 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 8 papers in Cognitive Neuroscience and 8 papers in Hematology. Recurrent topics in Avery A. Rizio's work include Hemoglobinopathies and Related Disorders (7 papers), Iron Metabolism and Disorders (6 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers). Avery A. Rizio is often cited by papers focused on Hemoglobinopathies and Related Disorders (7 papers), Iron Metabolism and Disorders (6 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers). Avery A. Rizio collaborates with scholars based in United States, United Kingdom and Japan. Avery A. Rizio's co-authors include Nancy A. Dennis, Michèle T. Diaz, Michelle K. White, Jakob Bue Bjørner, Stephen Maher, Jie Zhuang, Kristen McCausland, Mark Kosinski, Benjamin Carroll and Sanjay Gandhi and has published in prestigious journals such as Blood, PLoS ONE and Neurology.

In The Last Decade

Avery A. Rizio

28 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Avery A. Rizio United States	10	192	62	58	57	47	29	415
Rachel E. Siciliano United States	12	92 0.5×	41 0.7×	62 1.1×	34 0.6×	44 0.9×	30	377
Michelle Downes Ireland	10	157 0.8×	25 0.4×	45 0.8×	147 2.6×	11 0.2×	31	364
Elizabeth Cox United States	12	46 0.2×	27 0.4×	54 0.9×	22 0.4×	17 0.4×	36	512
Stephen Maher United States	15	178 0.9×	76 1.2×	9 0.2×	101 1.8×	16 0.3×	30	617
Michelle Lee United States	9	87 0.5×	22 0.4×	17 0.3×	31 0.5×	47 1.0×	18	511
Thomas R Valentine United States	10	56 0.3×	59 1.0×	71 1.2×	45 0.8×	12 0.3×	19	411
Matthew Scoggins United States	13	80 0.4×	41 0.7×	175 3.0×	41 0.7×	68 1.4×	30	505
Nicole Müller Germany	10	31 0.2×	25 0.4×	40 0.7×	19 0.3×	13 0.3×	43	376
Francesca Cavalleri Italy	10	90 0.5×	8 0.1×	22 0.4×	67 1.2×	20 0.4×	25	352
H. Allison Bender United States	15	207 1.1×	74 1.2×	9 0.2×	330 5.8×	21 0.4×	33	717

Countries citing papers authored by Avery A. Rizio

Since Specialization

Citations

This map shows the geographic impact of Avery A. Rizio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avery A. Rizio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avery A. Rizio more than expected).

Fields of papers citing papers by Avery A. Rizio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Avery A. Rizio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avery A. Rizio. The network helps show where Avery A. Rizio may publish in the future.

Co-authorship network of co-authors of Avery A. Rizio

This figure shows the co-authorship network connecting the top 25 collaborators of Avery A. Rizio. A scholar is included among the top collaborators of Avery A. Rizio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Avery A. Rizio. Avery A. Rizio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rizio, Avery A., et al.. (2025). SUN-052 Effects of Paltusotine Treatment on Patient-Reported Symptoms of Acromegaly in Phase 3 Randomized Placebo-Controlled Studies (PATHFNDR-2 and PATHFNDR-1). Journal of the Endocrine Society. 9(Supplement_1).

Dingli, David, Avery A. Rizio, Lynne Broderick, et al.. (2024). Health-related quality of life and symptom-specific functional impairment among patients treated with parenterally administered complement inhibitors for paroxysmal nocturnal hemoglobinuria. Annals of Hematology. 103(12). 5213–5227. 1 indexed citations

Campbell, Andrew, Avery A. Rizio, Kristen McCausland, et al.. (2023). The Burden of Sickle Cell Disease on Children and Their Caregivers: Caregiver Reports of Children’s Health-Related Quality of Life and School Experiences, Caregiver Burden, and Their Association with Frequency of Vaso-Occlusive Crises. Patient Related Outcome Measures. Volume 14. 369–381. 2 indexed citations

Rizio, Avery A., Michelle K. White, Anita D’Souza, et al.. (2023). Health-Related Quality of Life Instruments for Clinical Trials in AL Amyloidosis: Report from the Amyloidosis Forum HRQOL Working Group. Patient Related Outcome Measures. Volume 14. 153–169. 10 indexed citations

Dingli, David, Avery A. Rizio, Lynne Broderick, et al.. (2023). Health-Related Quality of Life and Symptom-Specific Functional Impairment Among Patients Treated with Parenterally Administered Complement Inhibitors for Paroxysmal Nocturnal Hemoglobinuria. Blood. 142(Supplement 1). 5126–5126. 1 indexed citations

White, Michelle K., et al.. (2021). Content validation of observer-reported sickle cell pain diaries (SCPD-CS and SCPD-CN): results from interviews with caregivers. Health and Quality of Life Outcomes. 19(1). 1 indexed citations

Shafrin, Jason, Howard Thom, Edna Keeney, et al.. (2021). The impact of vaso-occlusive crises and disease severity on quality of life and productivity among patients with sickle cell disease in the US. Current Medical Research and Opinion. 37(5). 761–768. 6 indexed citations

Becker, Brandon, et al.. (2021). Qualitative and psychometric approaches to evaluate the PROMIS pain interference and sleep disturbance item banks for use in patients with rheumatoid arthritis. Journal of Patient-Reported Outcomes. 5(1). 52–52. 8 indexed citations

Rizio, Avery A., Menaka Bhor, Xiaochen Lin, et al.. (2020). The relationship between frequency and severity of vaso-occlusive crises and health-related quality of life and work productivity in adults with sickle cell disease. Quality of Life Research. 29(6). 1533–1547. 43 indexed citations

10.

Rizio, Avery A., Lynne Broderick, Michelle K. White, & Tiffany P. Quock. (2020). <p>Content Validation of the ATTR Amyloidosis Patient Symptom Survey: Findings from Patient and Clinician Cognitive Debriefing Interviews</p>. Patient Related Outcome Measures. Volume 11. 149–160. 2 indexed citations

11.

Rizio, Avery A., et al.. (2019). PRO55 THE RELATIONSHIP BETWEEN VASO-OCCLUSIVE CRISES AND WORK PRODUCTIVITY IMPAIRMENT IN PATIENTS WITH SICKLE CELL DISEASE. Value in Health. 22. S345–S345. 1 indexed citations

12.

McEvoy, Joseph P., Sanjay Gandhi, Avery A. Rizio, et al.. (2019). Effect of tardive dyskinesia on quality of life in patients with bipolar disorder, major depressive disorder, and schizophrenia. Quality of Life Research. 28(12). 3303–3312. 37 indexed citations

13.

McCausland, Kristen, Avery A. Rizio, Michelle K. White, Martha Bayliss, & Tiffany P. Quock. (2019). Associations between Health-Related Quality of Life and Self-Reported Emergency Room Department Visits and Inpatient Hospitalizations: Insights from a Secondary Data Analysis of Patients with Light-Chain (AL) Amyloidosis. PharmacoEconomics - Open. 3(3). 367–375. 4 indexed citations

14.

White, Michelle K., Stephen Maher, Avery A. Rizio, & Jakob Bue Bjørner. (2018). A meta-analytic review of measurement equivalence study findings of the SF-36® and SF-12® Health Surveys across electronic modes compared to paper administration. Quality of Life Research. 27(7). 1757–1767. 38 indexed citations

15.

McEvoy, Joseph P., Benjamin Carroll, Sanjay Gandhi, et al.. (2018). Effect of Tardive Dyskinesia on Quality of Life: Patient-reported Symptom Severity is Associated with Deficits in Physical, Mental, and Social Functioning (P4.077). Neurology. 90(15_supplement). 2 indexed citations

16.

White, Michelle K., Martha Bayliss, Spencer Guthrie, et al.. (2017). Content validation of the SF-36v2® health survey with AL amyloidosis patients. Journal of Patient-Reported Outcomes. 1(1). 13–13. 11 indexed citations

17.

Rizio, Avery A. & Nancy A. Dennis. (2016). Recollection after inhibition: The effects of intentional forgetting on the neural correlates of retrieval. Cognitive Neuroscience. 8(1). 1–8. 6 indexed citations

18.

Rizio, Avery A. & Michèle T. Diaz. (2016). Language, aging, and cognition. Neuroreport. 27(9). 689–693. 44 indexed citations

19.

Rizio, Avery A. & Nancy A. Dennis. (2014). The Cognitive Control of Memory: Age Differences in the Neural Correlates of Successful Remembering and Intentional Forgetting. PLoS ONE. 9(1). e87010–e87010. 23 indexed citations

20.

Patterson, Carlyn A., et al.. (2008). Single unit activity in the rat superior colliculus during reward magnitude task performance.. Behavioral Neuroscience. 122(1). 183–190. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact